Jiping Liu Selected Research

Clofibrate

1/2022	Optimization of clofibrate with O-desmethyl anetholtrithione lead to a novel hypolipidemia compound with hepatoprotective effect.
1/2021	The combination of sesamol and clofibric acid moieties leads to a novel potent hypolipidemic agent with antioxidant, anti-inflammatory and hepatoprotective activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jiping Liu Research Topics

Disease

3	Inflammation (Inflammations) 01/2022 - 10/2015
3	Hyperlipidemias (Hyperlipidemia) 01/2022 - 01/2021
2	Atopic Dermatitis (Atopic Eczema) 06/2022 - 08/2020
2	COVID-19 10/2021 - 11/2020
2	Heart Failure 04/2020 - 12/2019
2	Asthma (Bronchial Asthma) 10/2015 - 07/2013
2	hypoglycemic encephalopathy 08/2013 - 07/2013
1	Dermatitis 06/2022
1	Spinal Cord Injuries (Spinal Cord Injury) 03/2022
1	Necrosis 01/2021
1	Deafness (Deaf Mutism) 01/2021
1	Osteoporosis 01/2021
1	Viral Pneumonia 11/2020
1	Vomiting 08/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2020
1	Thrombocytopenia (Thrombopenia) 08/2020
1	Nausea 08/2020
1	Leukopenia 08/2020
1	Diarrhea 08/2020
1	Nasopharyngeal Carcinoma 01/2020
1	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 01/2020
1	Unstable Angina 12/2019
1	Iron Deficiencies 01/2019
1	Hyperuricemia 10/2018
1	Brain Ischemia (Cerebral Ischemia) 09/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2017
1	Starvation 01/2016
1	Cognitive Dysfunction 04/2014
1	Eosinophilia 07/2013
1	Body Weight (Weight, Body) 07/2013

Drug/Important Bio-Agent (IBA)

3	tyloxapol FDA Link 01/2022 - 01/2021
3	Streptozocin (Streptozotocin)FDA Link 04/2014 - 07/2013
2	Triglycerides (Triacylglycerol)IBA 01/2022 - 12/2021
2	CholesterolIBA 01/2022 - 12/2021
2	Clofibrate FDA Link 01/2022 - 01/2021
2	AntioxidantsIBA 01/2021 - 07/2013
2	OvalbuminIBA 10/2015 - 07/2013
2	paeonolIBA 08/2013 - 07/2013
1	Interleukin-4 (Interleukin 4)IBA 06/2022
1	calcipotriene (calcipotriol)FDA LinkGeneric 06/2022
1	FlavonoidsIBA 06/2022
1	AcidsIBA 03/2022
1	CollagenIBA 03/2022
1	Hyaluronic Acid (Hyaluronan)IBA 03/2022
1	Fenofibrate (CiL)FDA LinkGeneric 12/2021
1	LipidsIBA 12/2021
1	sesaminIBA 12/2021
1	Biological ProductsIBA 10/2021
1	Small Cytoplasmic RNAIBA 10/2021
1	Interferon Type IIBA 10/2021
1	Clofibric AcidIBA 01/2021
1	Mitochondrial DNA (mtDNA)IBA 01/2021
1	sesamolIBA 01/2021
1	Hypolipidemic Agents (Antihyperlipidemics)IBA 01/2021
1	Dinitrochlorobenzene (DNCB)IBA 08/2020
1	Hemoglobins (Hemoglobin)IBA 08/2020
1	danhongIBA 04/2020
1	danshen dripping pillIBA 12/2019
1	shenqi fuzhengIBA 12/2019
1	Trimetazidine (Vastarel)IBA 12/2019
1	AluminumIBA 01/2019
1	Citric Acid (Citrate)FDA LinkGeneric 01/2019
1	NitrogenIBA 10/2018
1	Urea (Carbamide)FDA LinkGeneric 10/2018
1	HypoxanthineIBA 10/2018
1	CreatinineIBA 10/2018
1	Uric Acid (Urate)IBA 10/2018
1	qinpiIBA 10/2018
1	potassium oxonateIBA 10/2018
1	hydroxide ionIBA 09/2017
1	pilose antler peptideIBA 09/2017
1	dimethylarginineIBA 01/2017
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2017
1	Ecdysterone (20 Hydroxyecdysone)IBA 01/2016
1	astragalinIBA 10/2015
1	Pharmaceutical PreparationsIBA 10/2015
1	ginsenoside Rg5IBA 04/2014
1	Amyloid beta-PeptidesIBA 04/2014
1	Neuroprotective AgentsIBA 08/2013
1	InterleukinsIBA 07/2013
1	Interleukin-5 (Interleukin 5)IBA 07/2013
1	Interleukin-13IBA 07/2013
1	Advanced Glycation End ProductsIBA 07/2013
1	Glycated Serum ProteinsIBA 07/2013
1	Blood Glucose (Blood Sugar)IBA 07/2013
1	Hypoglycemic Agents (Hypoglycemics)IBA 07/2013

Therapy/Procedure

2	Therapeutics 11/2020 - 07/2013
1	Drug Therapy (Chemotherapy) 08/2020
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 08/2020
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2020